Bleomycin-induced fine structural alterations in cultured mouse fibroblasts and human lymphocytes of neoplastic origin.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D002460:Cell Line; D002466:Cell Nucleolus; D002467:Cell Nucleus; D002843:Chromatin; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects*; D006056:Golgi Apparatus; D006689:Hodgkin Disease; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D007945:Leukemia, Lymphoid; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects*; D051379:Mice; D008854:Microscopy, Electron; D008928:Mitochondria; D009040:Motion Pictures; D009369:Neoplasms
D000903:Antibiotics, Antineoplastic; D002843:Chromatin; D001761:Bleomycin